Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Lacerda · SciRah

Researcher profile · Semantic Scholar

A. Lacerda

Share profile

A. Lacerda — researcher profile on SciRah

h-index: 18
Works: 108
Citations: 1,756

Most-cited papers

Upadacitinib Induction and Maintenance Therapy for Crohn's Disease.
E. Loftus, J. Panés, A. Lacerda, L. Peyrin-Biroulet +15 more
2023New England Journal of Medicine352 citations Open access
Semantic Scholar
Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn's Disease.
W. Sandborn, B. Feagan, E. Loftus, L. Peyrin-Biroulet +18 more
2020Gastroenterology287 citations Open access
Semantic Scholar
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis
G. Burmester, S. Cohen, K. Winthrop, P. Nash +10 more
2023RMD Open199 citations Open access
Semantic Scholar
A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases
E. Vangeli, Savita Bakhshi, A. Baker, A. Fisher +6 more
2015Advances in Therapy146 citations Open access
Semantic Scholar
Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis
G. Burmester, R. Landewé, M. Genovese, A. Friedman +3 more
2016Annals of the Rheumatic Diseases106 citations Open access
Semantic Scholar
Safety and Efficacy of ABT-494 (Upadacitinib), an Oral Jak1 Inhibitor, as Induction Therapy in Patients with Crohn's Disease: Results from Celest
W. Sandborn, B. Feagan, J. Panés, G. D'Haens +6 more
201782 citations
Semantic Scholar
Upadacitinib Was Efficacious and Well Tolerated Over 30 Months in Patients with Crohn's Disease in the CELEST Extension Study.
G. D'Haens, J. Panés, E. Louis, A. Lacerda +3 more
2021Clinical Gastroenterology and Hepatology58 citations Open access
Semantic Scholar
Efficacy and Safety of Upadacitinib for Perianal Fistulizing Crohn's Disease: A Post Hoc Analysis of 3 Phase 3 Trials.
J. Colombel, A. Lacerda, P. Irving, R. Panaccione +10 more
2024Clinical Gastroenterology and Hepatology48 citations Open access
Semantic Scholar
Performance of Crohn's disease Clinical Trial Endpoints based upon Different Cutoffs for Patient Reported Outcomes or Endoscopic Activity: Analysis of EXTEND Data.
B. Feagan, W. Sandborn, P. Rutgeerts, B. Levesque +8 more
2018Inflammatory Bowel Diseases40 citations
Semantic Scholar
Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease.
James D. Lewis, P. Rutgeerts, B. Feagan, G. D'Haens +14 more
2019Inflammatory Bowel Diseases39 citations Open access
Semantic Scholar
Pregnancy Outcomes in Patients Treated with Upadacitinib: Analysis of Data from Clinical Trials and Postmarketing Reports
U. Mahadevan, Gweneth Levy, Lianne S. Gensler, Mira Ali +9 more
2024Drug Safety32 citations Open access
Semantic Scholar
Upadacitinib Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy.
J. Colombel, T. Hisamatsu, R. Atreya, F. Bresso +10 more
2024Clinical Gastroenterology and Hepatology28 citations Open access
Semantic Scholar
Randomized Controlled Trial Substudy of Cell-specific Mechanisms of Janus Kinase 1 Inhibition With Upadacitinib in the Crohn’s Disease Intestinal Mucosa: Analysis From the CELEST Study
D. Aguilar, Lluís Revilla, A. Garrido-Trigo, J. Panés +8 more
2021Inflammatory Bowel Diseases26 citations Open access
Semantic Scholar
Characterization of the Effect of Hepatic Impairment on Upadacitinib Pharmacokinetics
Sheryl Trueman, M. Mohamed, T. Feng, A. Lacerda +2 more
2019Journal of clinical pharmacology25 citations Open access
Semantic Scholar
Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic Exposure.
L. Peyrin-Biroulet, R. Panaccione, É. Louis, R. Atreya +15 more
2024Clinical Gastroenterology and Hepatology24 citations Open access
Semantic Scholar
Exposure–Response Analyses for Upadacitinib Efficacy and Safety in the Crohn's Disease CELEST Study and Bridging to the Extended‐Release Formulation
M. Mohamed, Ben Klünder, A. Lacerda, A. Othman
2019Clinical pharmacology and therapy22 citations Open access
Semantic Scholar
P273 Efficacy and safety of upadacitinib maintenance treatment for moderate to severe Crohn’s disease: Results from the CELEST study
J. Panés, W. Sandborn, E. Loftus, G. Van Assche +6 more
201820 citations
Semantic Scholar
P491 Efficacy and safety of upadacitinib for the treatment of fistulas and fissures in patients with Crohn’s disease
J. Colombel, P. Irving, F. Rieder, R. Panaccione +10 more
2023Journal of Crohn's & Colitis18 citations Open access
Semantic Scholar
Impact of Upadacitinib Induction and Maintenance Therapy on Health-related Quality of Life, Fatigue, and Work Productivity in Patients with Moderately-to-severely Active Crohn’s Disease
Subrata Ghosh, B. Feagan, R. Parra, Susana Lopes +10 more
2024Journal of Crohn's & Colitis13 citations Open access
Semantic Scholar
OP022 Rapidity of clinical and laboratory improvements following upadacitinib induction treatment: data from the CELEST study
S. Schreiber, L. Peyrin-Biroulet, B. Boland, P. Higgins +7 more
201813 citations Open access
Semantic Scholar
Association Between Proposed Definitions of Clinical Remission/Response and Well-Being in Patients With Crohn’s Disease
W. Sandborn, James D. Lewis, J. Panés, E. Loftus +6 more
2021Journal of Crohn's & Colitis10 citations Open access
Semantic Scholar
Efficacy and safety of upadacitinib maintenance therapy in patients with moderately to severely active Crohn’s disease: 2-year results from the U-ENDURE Long-Term Extension study
E. Loftus, G. D'Haens, Edouard Louis, M. Regueiro +14 more
2025Journal of Crohn's & Colitis9 citations Open access
Semantic Scholar
Quality of Life and Work Productivity Improvements with Upadacitinib: Phase 2b Evidence from Patients with Moderate to Severe Crohn’s Disease
L. Peyrin-Biroulet, E. Louis, E. Loftus, A. Lacerda +3 more
2021Advances in Therapy8 citations Open access
Semantic Scholar
OP14 Improved endoscopic outcomes and mucosal healing of upadacitinib as an induction therapy in adults with moderately to severely active ulcerative colitis: data from the U-ACHIEVE study
W. Sandborn, S. Schreiber, S. Lee, J. Lindsay +7 more
2019Journal of Crohn's & Colitis8 citations
Semantic Scholar
Upadacitinib Maintenance Therapy in Crohn's Disease: Final Results From the Randomized Phase 3 U-ENDURE Study.
R. Panaccione, Miguel D. Regueiro, Scott D. Lee, R. Atreya +12 more
2025Clinical Gastroenterology and Hepatology7 citations Open access
Semantic Scholar
Induction of Endoscopic Response, Remission, and Ulcer-Free Endoscopy With Upadacitinib Is Associated With Improved Clinical Outcomes and Quality of Life in Patients With Crohn’s Disease
Julián Panés, Edouard Louis, P. Bossuyt, N. Joshi +6 more
2024Inflammatory Bowel Diseases7 citations Open access
Semantic Scholar
867f: EFFICACY AND SAFETY OF UPADACITINIB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE WHO FAILED PRIOR BIOLOGICS: RESULTS FROM A RANDOMIZED PHASE 3 U-EXCEED STUDY
J. Colombel, J. Panés, A. Lacerda, L. Peyrin-Biroulet +13 more
2022Gastroenterology7 citations
Semantic Scholar
DOP50 Effect of upadacitinib on extra-intestinal manifestations in patients with moderate to severe Crohn’s disease: data from the CELEST study
L. Peyrin-Biroulet, S. Danese, E. Louis, P. Higgins +6 more
2019Journal of Crohn's & Colitis7 citations
Semantic Scholar
P601 Upadacitinib improves steroid-free clinical and endoscopic endpoints in patients with Crohn’s disease: Data from the CELEST study
R. Panaccione, R. Atreya, M. Ferrante, M. Dubinsky +8 more
20187 citations
Semantic Scholar
906 - Efficacy and Safety of Upadacitinib Maintenance Treatment for Moderate to Severe Crohn's Disease: Results from the Celest Study
J. Panés, W. Sandborn, E. Loftus, G. Van Assche +6 more
20187 citations
Semantic Scholar
OP16 Endoscopic and clinical outcomes of upadacitinib in patients with moderately to severely active Crohn’s disease by number and type of prior biologics
L. Peyrin-Biroulet, G. Parkes, C. Rodríguez, J. Siffledeen +8 more
2023Journal of Crohn's & Colitis6 citations Open access
Semantic Scholar
P843 Upadacitinib-induced endoscopic improvement is associated with modulation of pathways involved in Crohn’s disease pathogenesis
D. Aguilar, N. Planell, J. Panés, A. Lacerda +3 more
20186 citations
Semantic Scholar
Pharmacokinetics and Exposure–Response Analyses to Support Dose Selection of Upadacitinib in Crohn's Disease
Sumit Bhatnagar, Louisa Schlachter, D. Eckert, S. Stodtmann +3 more
2024Clinical pharmacology and therapy5 citations Open access
Semantic Scholar
Water fluoridation in the ten largest municipalities of the state of Tocantins, Brazil.
A. Lacerda, N. D. de Oliveira, H. H. C. Pinheiro, Karina Maschietto de Lima Assis +1 more
2020Ciência & Saúde Coletiva5 citations Open access
Semantic Scholar
Long-term Safety of Upadacitinib in Patients with Inflammatory Bowel Disease: Integrated Analysis of Phase 2/3 Studies.
R. Panaccione, J. Panés, L. Peyrin-Biroulet, J. Colombel +16 more
2026Clinical Gastroenterology and Hepatology4 citations Open access
Semantic Scholar
P434 Upadacitinib improved fatigue and health-related quality of life in patients with moderately to severely active Crohn’s disease: Results from induction and maintenance phase 3 trials
S. Ghosh, B. Feagan, R. Parra, S. Lopes +9 more
2023Journal of Crohn's & Colitis4 citations Open access
Semantic Scholar
OP17 Upadacitinib Improves Endoscopic Outcomes in Patients with Moderate to Severely Active Crohn’s Disease Irrespective of Previous Failure to Respond to Biologics or Conventional Therapies
B. Feagan, S. Horst, G. Dryden, J. Lindsay +9 more
2023Journal of Crohn's & Colitis4 citations Open access
Semantic Scholar
P630 Upadacitinib Improves Clinical Outcomes in Patients with Moderate to Severely Active Crohn’s Disease Irrespective of Previous Failure to Respond to Biologics or Conventional Therapies
S. Schreiber, A. Lim, A. Lacerda, J. Allegretti +8 more
2023Journal of Crohn's & Colitis4 citations Open access
Semantic Scholar
S736 Efficacy and Safety of Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Crohn’s Disease: Results From a Randomized Phase 3 U-EXCEL Study
E. Loftus, J. Colombel, A. Lacerda, L. Peyrin-Biroulet +14 more
2022American Journal of Gastroenterology4 citations
Semantic Scholar
DOP79 Dose escalation of upadacitinib in Crohn’s disease patients with an inadequate response: Data from the randomised CELEST study
W. Sandborn, J. Panés, L. Peyrin-Biroulet, E. Louis +5 more
20204 citations Open access
Semantic Scholar
800 – Improved Endoscopic Outcomes and Mucosal Healing of Upadacitinib As an Induction Therapy in Adults with Moderately-To-Severely Active Ulcerative Colitis: Data from the U-Achieve Study
W. Sandborn, S. Schreiber, S. Lee, J. Lindsay +7 more
2019Gastroenterology4 citations
Semantic Scholar
Sa1758 - Upadacitinib Improves Steroid-Free Clinical and Endoscopic Endpoints in Patients with Crohn's Disease: Data from the Celest Study
R. Panaccione, R. Atreya, M. Ferrante, M. Dubinsky +8 more
20184 citations
Semantic Scholar
DOP38 Upadacitinib Therapy Reduces Crohn’s Disease Symptoms Within the First Week of Induction Therapy
J. Colombel, T. Hisamatsu, Francesca Bresso, L. Thin +8 more
2023Journal of Crohn's & Colitis3 citations Open access
Semantic Scholar
HPV: a importância da vacinação para redução do surgimento de lesões pré-malignas do câncer de colo uterino
Ana Júlia Vilela Faria, A. Barroso, A. Lacerda, Bruna Marçal Carvalho Mendes +6 more
20213 citations Open access
Semantic Scholar
P533 Correlation of endoscopic and clinical endpoints during induction therapy in patients with moderate-to-severe Crohn’s disease: Analysis from CELEST study
W. Sandborn, B. Feagan, James D. Lewis, S. Danese +7 more
20183 citations Open access
Semantic Scholar
OP10 Efficacy and safety of upadacitinib in patients with moderately to severely active Crohn’s Disease: results from the U-ENDURE long-term extension
G. D'Haens, E. Louis, E. Loftus, M. Regueiro +11 more
2024Journal of Crohn's & Colitis2 citations Open access
Semantic Scholar
DOP40 Corticosteroid discontinuation and clinical outcomes in patients with moderately to severely active Crohn’s disease treated with upadacitinib
M. Dubinsky, G. D'Haens, O. Dewit, P. Juillerat +10 more
2023Journal of Crohn's & Colitis2 citations Open access
Semantic Scholar
S37 Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients With Moderately to Severely Active Crohn’s Disease: U-ENDURE Phase 3 Results
J. Panés, E. Loftus, A. Lacerda, L. Peyrin-Biroulet +13 more
2022American Journal of Gastroenterology2 citations
Semantic Scholar
Sa1755 - Rapidity of Clinical and Laboratory Improvements Following Upadacitinib Induction Treatment: Data from the Celest Study
S. Schreiber, L. Peyrin-Biroulet, B. Boland, P. Higgins +7 more
20182 citations
Semantic Scholar
Association of Bile Acid Diarrhea with Symptoms and Disease Activity in Crohn's Disease: Post-Hoc Clinical Trial Analysis of Serum 7a-hydroxy-4cholestern-3-one, C4, in Patients with Active Crohn's Disease.
R. Battat, Soumya Kandi, A. Lacerda, P. Levine +6 more
2025Journal of Crohn's & Colitis1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Qian Zhou×14
Invite
Qian Zhou — researcher profile on SciRah
J. Panés×13
Invite
J. Panés — researcher profile on SciRah
R. Panaccione×13
Invite
R. Panaccione — researcher profile on SciRah
L. Peyrin-Biroulet×12
Invite
L. Peyrin-Biroulet — researcher profile on SciRah

×11

Invite

W. Sandborn — researcher profile on SciRah

Invite

G. D'Haens — researcher profile on SciRah

Invite

F. Cataldi — researcher profile on SciRah

Invite

W. Reinisch — researcher profile on SciRah

Invite

M. Mohamed — researcher profile on SciRah

Invite

E. Dubcenco — researcher profile on SciRah

Invite

B. Feagan — researcher profile on SciRah

Invite

E. Loftus — researcher profile on SciRah